Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

monafram

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Monoclonal AntibodiesPeptide Fragments

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Binding of Coagulation Factor XIII Zymogen to Activated Platelet Subpopulations: Roles of Integrin αIIbβ3 and Fibrinogen.
Factor XIIIa (fXIIIa) is a transglutaminase that plays a crucial role in fibrin clot stabilization and regulation of fibrinolysis… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2014
2014
An effect of glycoprotein IIb/IIIa inhibitors on the kinetics of red blood cells aggregation.
The reversible aggregation of red blood cells (RBCs) continues to be of the basic science and clinical interest. Recently it has… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 6
  • figure 7
2012
2012
Red blood cells (dis)aggregation: effect of inhibition of fibrinogen binding
There are complex interactions between blood cells, and erythrocytes may enhance platelet aggregation. However, there is a lack… Expand
  • table 1
  • table 2
2012
2012
Identification of signal transduction pathways involved in the formation of platelet subpopulations upon activation
Platelets are formed elements of blood. Upon activation, they externalize phosphatidylserine, thus accelerating membrane… Expand
2011
2011
EFFICACY AND SAFETY OF GLYCOPROTEIN IIB/IIIA BLOCKER MONOFRAM IN CORONARY STENTING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
Aim. To study of efficacy and safety of glycoprotein IIb/IIIa blocker monafram in acute ST-segment elevation myocardial… Expand
2010
2010
[Glycoprotein IIb-IIIa antagonist Monafram in primary angioplasty of patients with acute coronary syndrome without st segment elevation].
Glycoprotein (GP) llb-llla anagonist monafram is the F(ab)2 fragments of anti GP llb llla monoclonal antibody FraMon (CRC64… Expand
2007
2007
Effects of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro polymorphism on platelet aggregation and sensitivity to glycoprotein IIb-IIIa antagonists
We investigated the influence of glycoprotein (GP) IIIa Leu33Pro polymorphism, platelet GP IIb-IIIa number, and plasma fibrinogen… Expand
2005
2005
Ability of Different Glycoprotein IIb-IIIa Ligands to Support Platelet Aggregation Induced by Activating Antibody CRC54
The ability of different ligands of glycoprotein (GP) IIb-IIIa (αIIb/β3-integrin) to support platelet aggregation stimulated by… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2005
2005
[Results of clinical trials of a novel glycoprotein IIb-IIIa antagonist framon in high-risk coronary angioplasty].
New glycoprotein (GP) IIb-IIIa antagonist preparation framon (Monafram), is the F(ab')(2) fragment of a monoclonal antibody… Expand
2004
2004
[Antiplatelet effects of glycoproteins IIb-IIIa antagonist monafram].
First Russian glycoprotein (GP) IIb-IIIa antagonist, preparation Monafram, is the F(ab')2 fragment of anti-GP IIb-IIIa monoclonal… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE